Searched for
SUN PHARMA JV
Amnish Aggarwal on 7 pharma and insurance stocks to bet on“Insurance is one of the most interesting segments in the long term. Over the last two to three years, insurance stocks have underperformed...
India Inc's overseas direct investment declines 31% to $1.85 billion in FebruaryOf the total investment made by Indian companies in foreign markets, USD 1.36 billion was in the form of loan; USD 297.37 million comprised...
Strides inks JV pact with China's Sihuan PharmaSihuan will leverage its over 4,000 strong sales force and 3,000 plus distributors across Mainland China to market the products.
As going gets tough, pharma firms revisit past decisionsCompanies have rationalised field force and restructured product portfolio to up productivity.
Right time to pick up pharma stocks: Yogesh Mehta, Motilal Oswal SecuritiesPharma is in doldrums, nobody is looking at it and this is the right time to pick up pharma stocks for the portfolio.
Indian generic drug makers like Lupin, Dr Reddy’s Laboratories, Sun Pharma eye Japanese marketIn April, Lupin formed a joint venture with Japan’s Yoshindo for biosimilars. It is also in talks with other local drug makers for alliance...
Glenmark's anti-diabetes drugs shake up Indian anti-diabetes marketThe company has raked in Rs 16 crore in just 8 months since drug was launched.
Sun Pharma gains on JV to develop new drugsThe joint venture will leverage Sun Pharma’s global capabilities and experience in developing and manufacturing complex dosage forms and sp...
Sun Pharma may fund new telecom joint-venture with TelenorIndia's fifth largest pharma company Sun Pharma may indirectly finance its executive director Sudhir Valia's investment in Telewings Commun...
Sun Pharma's promoters to be Telenor's new Indian JV partnerAfter months of searching, Telenor has finally found a new partner for its telecom operations in India - Sun Pharma's promoters.
Sun Pharmaceuticals spins off home formulation businessThe move sparked a fair bit of speculation on the domestic unit, and a range of theories - like bringing in a foreign partner to a possible...
- Short-term outlook positive for pharma stocks: JV Capital Services
Buy with dips until the momentum is broken but for sure, short-term outlook is still reasonably positive for these stocks.
- Sun Pharma, Cipla best bet among pharma stocks: Sajiv Dhawan
Most of the times these stocks will trade in a range. It is not a sector that I say would outperform even in the next year or so.
- 'Pharma not the best sector to bet on amidst US FDA compliance issues'
"The reality at present is that the pharma stocks are always subject to problems with US FDA regulations," says Sajiv Dhawan of JV Capital.
- Pharma not the best sector for short-term traders: Sajiv Dhawan
"Pharma is not one of the most glamorous sectors and from a short-term traders perspective, probably not the best sector to pick on. "
- Merck, Sun Pharma ink JV to bring innovative drugs to EMs
Sun Pharmaceutical will bring its product development skills to the table, while Merck will help with market presence.
- Accumulate Sun Pharma: Sajiv Dhawan, JV Capital Services
Sun Pharma has performed better from the stock market perspective
- AIG holdings in local cos under a cloud
The $85 bn bailout of AIG by US govt in exchange for 79.9% equity interest may land several cos in unique regulatory hassle. History of: AI...
- Pharma cos set sights on Japan
As pricing pressure intensifies in the US generics market, Indian pharma majors are planning rapid inroads into Japan, which is the worlds ...
- Forthcoming events this week
Forthcoming events this week